EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

Yixuan Duan, Miaohan Qiu, Kun Na, Daoshen Liu, Shangxun Zhou, Ying Xu, Zizhao Qi, Haiwei Liu, Kai Xu, Xiaozeng Wang, Jing Li, Yi Li und 1 weitere

Thrombosis and Haemostasis · 01.12.2025 · 125 (12) · 1256-1265

DOI: 10.1055/a-2531-3268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.12.2025. Verfasst von Yixuan Duan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, State Key Laboratory of Frigid Zone Cardiovascular Disease, General Hospital of Northern Theater Command, Shenyang, China. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Percutaneous Coronary Intervention, Hemorrhage, Inflammation. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate the impact of systemic inflammation burden using high-sensitivity C-reactive protein (hsCRP) and long-term prognosis in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) stratified by bleeding risk status. Consecutive patients admitted for ACS and who received PCI between March 2016 and March 2022 were enrolled in the analysis. Elevated systemic inflammation was defined as hsCRP >2 mg/L, and high bleeding risk (HBR) was defined the Academic Research Consortium (ARC)-HBR criteria. The primary outcome was ischemic events at 12 months, composed of cardiac death, myocardial infarction, and/or stroke. The main secondary outcomes included all-cause death, and Bleeding Academic Research Consortium (BARC) types 2, 3, and 5 bleeding and types 3 and 5 bleeding. Of 15,013 patients, 4,606 (30.7%) were qualified as HBR and 8,395 (55.9%) had hsCRP >2 mg/L. Elevated hsCRP was consistently associated with higher risk of ischemic events in both HBR (adjusted hazard ratio [aHR]: 1.20; 95% confidence interval [CI]: 0.91–1.58) and non-HBR (aHR: 1.34; 95% CI: 1.01–1.78) subgroups (P interaction = 0.755). Although the incidence of bleeding events was higher in HBR patients, an elevated hsCRP level was not associated with bleeding events regardless of HBR status. Restricted cubic spline regression represented an inverse J-shaped relation between hsCRP and non-HBR for ischemic events (P nonlinearity

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromePercutaneous Coronary InterventionHemorrhageInflammationHumansMaleFemaleAgedMiddle AgedC-Reactive ProteinRisk FactorsTreatment OutcomeRisk AssessmentPrognosisBiomarkers

Substanzen

C-Reactive ProteinBiomarkers

Autor:innen und Institutionen

  • Department of Cardiology, State Key Laboratory of Frigid Zone Cardiovascular Disease, General Hospital of Northern Theater Command, Shenyang, China.
  • The Department of Cardiology, Air Force Medical University, Xijing Hospital, Xi'an, Shaanxi, China.

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Duan, Y., Qiu, M., Na, K., Liu, D., Zhou, S., Xu, Y., Qi, Z., Liu, H., Xu, K., Wang, X., Li, J., Li, Y., & Han, Y. (2025). Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention. Thrombosis and Haemostasis, 125(12), 1256-1265. https://doi.org/10.1055/a-2531-3268

Vancouver

Duan Y, Qiu M, Na K, Liu D, Zhou S, Xu Y, et al. Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention. Thrombosis and Haemostasis. 2025;125(12):1256-1265. doi:10.1055/a-2531-3268

BibTeX
@article{Duan2025,
  author = {Duan, Yixuan and Qiu, Miaohan and Na, Kun and Liu, Daoshen and Zhou, Shangxun and Xu, Ying and Qi, Zizhao and Liu, Haiwei and Xu, Kai and Wang, Xiaozeng and Li, Jing and Li, Yi and Han, Yaling},
  title = {Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention},
  journal = {Thrombosis and Haemostasis},
  year = {2025},
  volume = {125},
  number = {12},
  pages = {1256--1265},
  doi = {10.1055/a-2531-3268}
}
Kostenlos starten →